2026年全球藥物傳輸設備市場報告

近年來，藥物輸送裝置的市場規模顯著成長，預計將從2025年的959.9億美元成長到2026年的1,021.5億美元，複合年成長率為6.4%。過去幾年的成長歸因於慢性病盛行率上升、注射療法的推廣、院內給藥增加、輸液裝置的使用日益普及以及製劑技術的進步等因素。

預計未來幾年，藥物輸送設備市場將保持強勁成長，到2030年市場規模將達到1,289.4億美元，複合年成長率（CAGR）為6.0%。預測期內的成長要素包括：居家藥物輸送的普及率不斷提高、個人化醫療投資增加、生物製藥和生物類似藥的擴張、對互聯輸送設備的需求不斷成長以及數位健康平台的日益融合。預測期內的主要趨勢包括：智慧型藥物輸送設備的普及率不斷提高、自行注射系統的普及率不斷提高、對緩釋技術的需求不斷成長、穿戴式藥物輸送平台的擴張以及對以患者為中心的設計的日益重視。

預計未來幾年，不斷成長的醫療費用支出將推動藥物輸送設備市場的成長。醫療費用支出是指用於醫療保健相關服務和產品的總資金，包括醫院、醫生、護理、處方藥和公共衛生措施。人口老化、慢性病增加、醫療技術進步以及醫療服務和藥物成本上漲等因素導致醫療保健醫療費用支出不斷增加。不斷成長的醫療保健支出支持藥物輸送設備的發展，因為它能夠增加對研發和創新的投資，並促進先進技術的應用，從而提高治療效果和改善患者預後。例如，根據英國政府機構國家統計局 (ONS) 的數據，截至 2024 年 5 月，英國的醫療費用支出預計將在 2023 年達到約 3,790 億美元（2,920 億英鎊）。與 2022 年相比，這相當於名目成長 5.6%，遠高於上年度0.9% 的成長率。因此，醫療費用支出不斷成長，促進了藥物輸送設備市場的成長。

藥物遞送裝置市場的主要企業正致力於開發先進的解決方案，例如定向口服釋放膠囊，以提高治療效果並減少全身副作用。定向口服釋放膠囊旨在耐受胃部的酸性環境，並在胃腸道的特定部位精準釋放活性成分，從而提高生物利用度並實現局部治療。例如，總部位於德國的特種化學品和生命科學公司贏創於2024年9月推出了EUDRACAP結腸膠囊，該膠囊旨在將敏感的活性成分遞送至髂骨區域。這些膠囊能夠遞送活體生物製藥、口服生物製藥、胜肽、蛋白質和核苷酸，並透過客製化設計的EUDRAGIT包衣保持其穩定性。 EUDRACAP結腸膠囊採用即用型設計，簡化了製劑開發流程，降低了開發複雜性，並加快了產品上市速度。這項進展擴展了贏創的EUDRACAP平台，並增強了其用於先進口服藥物遞送的系統解決方案組合。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球藥物輸送設備市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 人工智慧與自主智慧
  • 生物技術、基因組學和精準醫學
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 智慧型藥物傳輸裝置的應用日益普及
  • 自行注射系統日益普及
  • 緩釋技術的需求不斷成長
  • 擴展穿戴式藥物輸送平台
  • 越來越重視以病人為中心的設計

第5章 終端用戶產業市場分析

• 醫院
• 診斷中心
• 門診手術中心
• 居家照護提供者
• 專科診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球藥物輸送設備市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球藥物傳輸設備市場規模、比較及成長率分析
• 全球藥物傳輸設備市場表現：規模與成長，2020-2025年
• 全球藥物輸送設備市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 透過行政途徑
• 口服給藥、注射給藥、局部給藥、眼部給藥、肺部給藥、鼻腔給藥、粘膜給藥、植入式給藥
• 患者照護場所
• 醫院、診斷中心、門診手術中心/診所、居家醫療機構和其他患者照護場所
• 透過使用
• 癌症、感染疾病、呼吸系統疾病、糖尿病、心血管疾病、自體免疫疾病、中樞神經系統疾病及其他適應症
• 按類型細分：口服給藥
• 錠劑和膠囊、口腔噴霧、口服液、口溶錠
• 按類型細分：注射給藥
• 注射器（手動和自動丟棄式）、管瓶和藥筒、注射筆、輸液泵
• 按類型細分：局部藥物輸送
• 乳膏和軟膏、經皮吸收貼片、凝膠和洗劑、粉劑
• 按類型細分：眼科藥物遞送
• 眼藥水、眼內植入物、隱形眼鏡給藥系統
• 按類型細分：肺部給藥
• 定量噴霧吸入器（MDI）、乾粉吸入器（DPI）、霧化器
• 按類型細分：鼻內給藥
• 鼻噴劑、鼻粉和滴鼻劑
• 按類型細分：粘膜給藥
• 口腔黏膜片、舌下片、黏膜黏附膜
• 按類型細分：植入式藥物傳輸系統
• 藥物植入式裝置、可生物分解植入、儲液囊型植入

第10章 區域與國家分析

• 全球藥物傳輸設備市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
• 全球藥物輸送設備市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 藥物輸送裝置市場：競爭格局及市場佔有率（2024年）
• 藥物輸送設備市場：公司估值矩陣
• 藥物輸送設備市場：公司概況
  • Becton Dickinson and Company
  • Baxter International
  • B. Braun Melsungen AG
  • Catalent
  • West Pharmaceutical Services Inc.

第37章：其他領先和創新企業

• Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年藥物輸送設備市場：提供新機會的國家
• 2030年藥物輸送設備市場：充滿新機會的細分市場
• 2030年藥物傳輸設備市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Drug delivery devices are designed to administer specific drugs to targeted areas of the body for disease treatment. These devices find application in various patient care environments, including hospitals, diagnostic centers, clinics, and home care settings.

The primary routes of drug administration through these devices encompass oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. Oral drug delivery involves the administration of a tablet or capsule into the alimentary canal of a human being. Patient care settings where these devices are utilized include hospitals, diagnostic centers, ambulatory surgery centers/clinics, home care settings, and others. The diverse applications of these drug delivery devices span across areas such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, and more.

Tariffs are impacting the drug delivery devices market by increasing costs of imported polymers, electronic components, precision molds, sensors, and infusion system parts used across injectables, inhalers, and implantable devices. Healthcare providers and device manufacturers in North America and Europe are most affected due to reliance on cross-border component sourcing, while Asia-Pacific faces export-related cost pressures. These tariffs are raising device prices and slowing procurement cycles. However, they are also driving localization of device manufacturing, regional supplier development, and innovation in cost-efficient delivery technologies.

The drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides drug delivery devices market statistics, including drug delivery devices industry global market size, regional shares, competitors with a drug delivery devices market share, detailed drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug delivery devices industry. This drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug delivery devices market size has grown strongly in recent years. It will grow from $95.99 billion in 2025 to $102.15 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, expansion of injectable therapies, growth in hospital-based drug administration, increasing use of infusion devices, advancements in pharmaceutical formulations.

The drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $128.94 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing adoption of home-based drug delivery, rising investments in personalized medicine, expansion of biologics and biosimilars, growing demand for connected delivery devices, increasing integration of digital health platforms. Major trends in the forecast period include increasing adoption of smart drug delivery devices, rising use of self-administration injection systems, growing demand for controlled release technologies, expansion of wearable drug delivery platforms, enhanced focus on patient-centric designs.

Rising healthcare expenditure is anticipated to drive the growth of the drug delivery devices market in the coming years. Healthcare spending refers to the total financial resources allocated to health-related services and products, including expenditures on hospitals, physicians, nursing care, prescription medicines, and public health initiatives. Healthcare spending is increasing due to factors such as an aging population, the growing prevalence of chronic diseases, advancements in medical technologies, and escalating costs of healthcare services and pharmaceuticals. Higher healthcare expenditure supports the development of drug delivery devices by enabling greater investment in research, innovation, and the adoption of advanced technologies that enhance treatment effectiveness and patient outcomes. For example, in May 2024, according to the Office for National Statistics, a UK-based government department, healthcare expenditure in the United Kingdom reached approximately $379 billion (£292 billion) in 2023. This represented a 5.6% nominal increase compared with 2022, a notable rise from the 0.9% growth recorded in the previous year. Therefore, increasing healthcare spending is contributing to the growth of the drug delivery devices market.

Leading players operating in the drug delivery devices market are focusing on the development of advanced solutions, such as targeted oral release capsules, to improve treatment efficacy and reduce systemic side effects. Targeted oral release capsules are designed to withstand the acidic conditions of the stomach and release active ingredients accurately in specific regions of the gastrointestinal tract, thereby enhancing bioavailability and localizing therapy. For instance, in September 2024, Evonik, a Germany-based specialty chemicals and life sciences company, introduced its EUDRACAP colon capsules, which are intended for the delivery of sensitive active substances to the ileo-colonic region. These capsules enable the administration of live biotherapeutic products, oral biologics, peptides, proteins, and nucleotides while maintaining their stability through customized EUDRAGIT coatings. The EUDRACAP colon capsules also simplify formulation development with a ready-to-fill design and accelerate time to market by reducing development complexity. This advancement expands Evonik's EUDRACAP platform and reinforces its system solutions portfolio for advanced oral drug delivery.

In October 2024, Aptar Pharma, a US-based supplier of drug delivery systems and active material science solutions, acquired the device technology assets of SipNose Nasal Delivery Systems for an undisclosed sum. Through this acquisition, Aptar seeks to broaden its intranasal drug delivery portfolio, strengthen its nose-to-brain delivery capabilities, and accelerate innovation in central nervous system therapeutic platforms. SipNose, an Israel-based company, develops intranasal delivery devices for both liquid and dry powder formulations, enabling local, systemic, and direct brain delivery of active ingredients.

Major companies operating in the drug delivery devices market are Becton Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, West Pharmaceutical Services Inc., Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical, Terumo Corporation, Gilero

North America was the largest region in the drug delivery devices market in 2025. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug delivery devices market consists of sales of instruments such as smart pills, inhalers and nebulizers, drug-eluting stents, safety syringes, and transdermal patches. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Route Of Administration: Oral Drug Delivery; Injectable Drug Delivery; Topical Drug Delivery; Ocular Drug Delivery; Pulmonary Drug Delivery; Nasal Drug Delivery; Transmucosal Drug Delivery; Implantable Drug Delivery
• 2) By Patient Care Setting: Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Home Care Settings; Other Patient Care Settings
• 3) By Application: Cancer; Infectious Diseases; Respiratory Diseases; Diabetes; Cardiovascular Diseases; Autoimmune Diseases; Central Nervous System Disorders; Other Applications
• Subsegments:
• 1) By Oral Drug Delivery: Tablets and Capsules; Oral Sprays; Oral Liquids; Oral Disintegrating Tablets
• 2) By Injectable Drug Delivery: Syringes (manual and auto-disable); Vials and Cartridges; Pen Injectors; Infusion Pumps
• 3) By Topical Drug Delivery: Creams and Ointments; Transdermal Patches; Gels and Lotions; Powders
• 4) By Ocular Drug Delivery: Eye Drops; Ocular Inserts; Contact Lens Drug Delivery Systems
• 5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers
• 6) By Nasal Drug Delivery: Nasal Sprays; Nasal Powders; Nasal Drops
• 7) By Transmucosal Drug Delivery: Buccal Tablets; Sublingual Tablets; Mucoadhesive Films
• 8) By Implantable Drug Delivery: Drug-Implantable Devices; Biodegradable Implants; Reservoir-based Implants
• Companies Mentioned: Becton Dickinson and Company; Baxter International; B. Braun Melsungen AG; Catalent; West Pharmaceutical Services Inc.; Gerresheimer AG; Smiths Medical; Elcam Medical; SMC Ltd.; Injex; Ypsomed Holding AG; Nemera; H&T Presspart; Syqe Medical; Antares Pharma; Julphar; Teleflex Medical; Kedalion Therapeutics; MediPrint Ophthalmics; Sorrel Medical; Terumo Corporation; Gilero
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Drug Delivery Devices Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Drug Delivery Devices Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Drug Delivery Devices Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Drug Delivery Devices Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence And Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics And Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
  • 4.1.4 Industry 4.0 And Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Smart Drug Delivery Devices
  • 4.2.2 Rising Use Of Self-Administration Injection Systems
  • 4.2.3 Growing Demand For Controlled Release Technologies
  • 4.2.4 Expansion Of Wearable Drug Delivery Platforms
  • 4.2.5 Enhanced Focus On Patient-Centric Designs

5. Drug Delivery Devices Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Centers
• 5.3 Ambulatory Surgery Centers
• 5.4 Home Care Providers
• 5.5 Specialty Clinics

6. Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Drug Delivery Devices Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Drug Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Drug Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Delivery Devices Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Delivery Devices Market Segmentation

• 9.1. Global Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
• 9.2. Global Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
• 9.3. Global Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications
• 9.4. Global Drug Delivery Devices Market, Sub-Segmentation Of Oral Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets
• 9.5. Global Drug Delivery Devices Market, Sub-Segmentation Of Injectable Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps
• 9.6. Global Drug Delivery Devices Market, Sub-Segmentation Of Topical Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders
• 9.7. Global Drug Delivery Devices Market, Sub-Segmentation Of Ocular Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems
• 9.8. Global Drug Delivery Devices Market, Sub-Segmentation Of Pulmonary Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
• 9.9. Global Drug Delivery Devices Market, Sub-Segmentation Of Nasal Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nasal Sprays, Nasal Powders, Nasal Drops
• 9.10. Global Drug Delivery Devices Market, Sub-Segmentation Of Transmucosal Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Buccal Tablets, Sublingual Tablets, Mucoadhesive Films
• 9.11. Global Drug Delivery Devices Market, Sub-Segmentation Of Implantable Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

10. Drug Delivery Devices Market Regional And Country Analysis

• 10.1. Global Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Delivery Devices Market

• 11.1. Asia-Pacific Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Delivery Devices Market

• 12.1. China Drug Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Delivery Devices Market

• 13.1. India Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Delivery Devices Market

• 14.1. Japan Drug Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Delivery Devices Market

• 15.1. Australia Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Delivery Devices Market

• 16.1. Indonesia Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Delivery Devices Market

• 17.1. South Korea Drug Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Delivery Devices Market

• 18.1. Taiwan Drug Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Delivery Devices Market

• 19.1. South East Asia Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Delivery Devices Market

• 20.1. Western Europe Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Delivery Devices Market

• 21.1. UK Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Delivery Devices Market

• 22.1. Germany Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Delivery Devices Market

• 23.1. France Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Delivery Devices Market

• 24.1. Italy Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Delivery Devices Market

• 25.1. Spain Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Delivery Devices Market

• 26.1. Eastern Europe Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Delivery Devices Market

• 27.1. Russia Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Delivery Devices Market

• 28.1. North America Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Delivery Devices Market

• 29.1. USA Drug Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Delivery Devices Market

• 30.1. Canada Drug Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Delivery Devices Market

• 31.1. South America Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Delivery Devices Market

• 32.1. Brazil Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Delivery Devices Market

• 33.1. Middle East Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Delivery Devices Market

• 34.1. Africa Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Delivery Devices Market Regulatory and Investment Landscape

36. Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 36.1. Drug Delivery Devices Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Drug Delivery Devices Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Drug Delivery Devices Market Company Profiles
  • 36.3.1. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Baxter International Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Catalent Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. West Pharmaceutical Services Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Drug Delivery Devices Market Other Major And Innovative Companies

• Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical

38. Global Drug Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Delivery Devices Market

40. Drug Delivery Devices Market High Potential Countries, Segments and Strategies

• 40.1 Drug Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Drug Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Drug Delivery Devices Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer